GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 4,000 Shares

November 15, 2012 | About:
insider

insider

56 followers
CEO of Biomarin Pharmaceutical, Inc. (BMRN) Jean Jacques Bienaime sells 4,000 shares of BMRN on 11/14/2012 at an average price of $48.5 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $5.94 billion; its shares were traded at around $47.98 with and P/S ratio of 13.5.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.


CEO Recent Trades:



  • CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 11/14/2012 at the average price of 48.5. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 1.07% since.
  • CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 11/09/2012 at the average price of 47.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 0.76% since.
  • CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 10/31/2012 at the average price of 37.96. Jean Jacques Bienaime owns at least 174,691 shares after this. The price of the stock has increased by 26.4% since.
  • CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 10/22/2012 at the average price of 41.86. Jean Jacques Bienaime owns at least 175,691 shares after this. The price of the stock has increased by 14.62% since.
  • CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 10/19/2012 at the average price of 42.72. Jean Jacques Bienaime owns at least 175,691 shares after this. The price of the stock has increased by 12.31% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.




Directors and Officers Recent Trades:



  • SVP, General Counsel George Eric Davis sold 99,075 shares of BMRN stock on 11/12/2012 at the average price of 48.45. George Eric Davis owns at least 51,322 shares after this. The price of the stock has decreased by 0.97% since.
  • SVP, Chief Commercial Of Jeffrey Robert Ajer sold 265 shares of BMRN stock on 11/12/2012 at the average price of 48.11. Jeffrey Robert Ajer owns at least 10,570 shares after this. The price of the stock has decreased by 0.27% since.
  • Director Elaine J Heron sold 1,875 shares of BMRN stock on 11/12/2012 at the average price of 48.33. Elaine J Heron owns at least 14,025 shares after this. The price of the stock has decreased by 0.72% since.
  • Director Elaine J Heron sold 135,000 shares of BMRN stock on 11/09/2012 at the average price of 46.79. Elaine J Heron owns at least 15,900 shares after this. The price of the stock has increased by 2.54% since.
  • Director Alan Lewis sold 15,000 shares of BMRN stock on 11/07/2012 at the average price of 46.8. Alan Lewis owns at least 15,900 shares after this. The price of the stock has increased by 2.52% since.


For the complete insider trading history of BMRN, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.3/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide